Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria

Erythropoietic protoporphyria (EPP) is a hereditary disease characterized by a deficiency in ferrochelatase (FECH) activity. FECH activity is responsible for the accumulation of protoporphyrin IX (PPIX). Without etiopathogenic treatment, EPP manifests as severe photosensitivity. 95% of affected indi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Hum Genet
Autors principals: Mirmiran, Arienne, Schmitt, Caroline, Lefebvre, Thibaud, Manceau, Hana, Daher, Raêd, Oustric, Vincent, Poli, Antoine, Lacapère, Jean-Jacques, Moulouel, Boualem, Puy, Hervé, Karim, Zoubida, Peoc'h, Katell, Lenglet, Hugo, Simonin, Sylvie, Deybach, Jean-Charles, Nicolas, Gaël, Gouya, Laurent
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369449/
https://ncbi.nlm.nih.gov/pubmed/30712775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajhg.2018.12.021
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars